Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) COO John Gallagher sold 6,383 shares of the firm’s stock in a transaction on Friday, November 28th. The stock was sold at an average price of $34.82, for a total value of $222,256.06. Following the transaction, the chief operating officer directly owned 32,721 shares of the company’s stock, valued at $1,139,345.22. The trade was a 16.32% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
Trupanion Price Performance
NASDAQ:TRUP opened at $34.84 on Wednesday. The company’s 50-day moving average is $40.35 and its two-hundred day moving average is $45.81. The company has a current ratio of 1.69, a quick ratio of 1.69 and a debt-to-equity ratio of 0.32. The firm has a market cap of $1.51 billion, a price-to-earnings ratio of 134.01 and a beta of 1.62. Trupanion, Inc. has a 12-month low of $31.00 and a 12-month high of $57.88.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its earnings results on Thursday, November 6th. The financial services provider reported $0.13 EPS for the quarter, missing the consensus estimate of $0.89 by ($0.76). The firm had revenue of $366.92 million during the quarter, compared to analysts’ expectations of $361.58 million. Trupanion had a return on equity of 3.31% and a net margin of 0.81%.The firm’s revenue was up 12.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.03 earnings per share. Research analysts expect that Trupanion, Inc. will post 0.13 EPS for the current year.
Institutional Trading of Trupanion
Analyst Ratings Changes
TRUP has been the subject of several research analyst reports. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of Trupanion in a research report on Monday. Wall Street Zen upgraded shares of Trupanion from a “hold” rating to a “buy” rating in a report on Saturday, November 8th. Cantor Fitzgerald upgraded Trupanion to a “hold” rating in a research note on Wednesday, August 13th. Stifel Nicolaus lowered their price objective on Trupanion from $45.00 to $42.00 and set a “hold” rating for the company in a report on Tuesday, November 18th. Finally, Piper Sandler lifted their price target on shares of Trupanion from $62.00 to $67.00 and gave the company an “overweight” rating in a report on Friday, August 8th. Two equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $54.00.
Check Out Our Latest Analysis on TRUP
Trupanion Company Profile
Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.
See Also
- Five stocks we like better than Trupanion
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Wall Street’s Sleeping Giant: Is Amazon About to Wake Up?
- Investing in Commodities: What Are They? How to Invest in Them
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- 3 Dividend Kings To Consider
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
